Starling Oncology, Inc. Operating Lease, Expense
Starling Oncology, Inc. (DFPH) reported Operating Lease, Expense of $4.28 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-03-11
- Starling Oncology, Inc. operating lease, expense for fiscal 2021 was $4.28M, a 16.33% increase from fiscal 2020.
- Starling Oncology, Inc. operating lease, expense for fiscal 2020 was $3.68M.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2021-12-31 | $4.28M 10-K · filed 2022-03-11 |
| 2020-12-31 | $3.68M 10-K · filed 2022-03-11 |